InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Aclaris Therapeutics, Inc.

ACRS Clue Score38
United States Fiscal year ends December CIK 0001557746
$3.83 +1.06% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $3.83 −78.24% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Operating income−48.6Net income−48.1Fiscal year 2017Revenue1.7Operating income−54.4Net income−68.5Fiscal year 2018Revenue6.2 +265.5%Operating income−84.8Net income−132.7Fiscal year 2019Revenue4.2 −31.3%Operating income−111.1Net income−161.4EPS, diluted−3.90Fiscal year 2020Revenue6.5 +53.3%Operating income−50.9Net income−51.0EPS, diluted−1.20Fiscal year 2021Revenue6.8 +4.3%Operating income−89.7Net income−90.9EPS, diluted−1.60Fiscal year 2022Revenue29.8 +340.1%Operating income−89.9Net income−86.9EPS, diluted−1.33Fiscal year 2023Revenue31.2 +5.0%Operating income−97.4Net income−88.5EPS, diluted−1.27Fiscal year 2024Revenue18.7 −40.1%Operating income−141.9Net income−132.1EPS, diluted−1.71Fiscal year 2025Revenue7.8 −58.2%Operating income−76.4Net income−64.9EPS, diluted−0.53
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a 1.7 6.2 4.2 6.5 6.8 29.8 31.2 18.7 7.8
Growth +265.5% −31.3% +53.3% +4.3% +340.1% +5.0% −40.1% −58.2%
Operating income −48.6 −54.4 −84.8 −111.1 −50.9 −89.7 −89.9 −97.4 −141.9 −76.4
Net income −48.1 −68.5 −132.7 −161.4 −51.0 −90.9 −86.9 −88.5 −132.1 −64.9
Growth
EPS, diluted n/a n/a n/a −3.90 −1.20 −1.60 −1.33 −1.27 −1.71 −0.53

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Fiscal year 2017Gross margin28.3%Operating margin−3,230.0%Net margin−4,071.5%Free cash flow margin−3,321.3%Fiscal year 2018Gross margin52.7%Operating margin−1,378.3%Net margin−2,158.0%Free cash flow margin−1,661.0%Fiscal year 2019Operating margin−2,627.3%Net margin−3,817.2%Free cash flow margin−2,319.8%Fiscal year 2020Operating margin−785.4%Net margin−787.0%Free cash flow margin−603.0%Fiscal year 2021Operating margin−1,327.1%Net margin−1,344.0%Free cash flow margin−775.7%Fiscal year 2022Operating margin−302.0%Net margin−292.1%Free cash flow margin−229.1%Fiscal year 2023Operating margin−311.6%Net margin−283.1%Free cash flow margin−254.8%Fiscal year 2024Operating margin−758.2%Net margin−705.5%Free cash flow margin−107.9%Fiscal year 2025Operating margin−975.9%Net margin−829.6%Free cash flow margin−603.4%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a 28.3% 52.7% n/a n/a n/a n/a n/a n/a n/a
Operating margin n/a −3,230.0% −1,378.3% −2,627.3% −785.4% −1,327.1% −302.0% −311.6% −758.2% −975.9%
Net margin n/a −4,071.5% −2,158.0% −3,817.2% −787.0% −1,344.0% −292.1% −283.1% −705.5% −829.6%
Free cash flow margin n/a −3,321.3% −1,661.0% −2,319.8% −603.0% −775.7% −229.1% −254.8% −107.9% −603.4%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−34.6Capital expenditure−0.2Free cash flow−34.8Fiscal year 2017Operating cash flow−54.7Capital expenditure−1.2Free cash flow−55.9Fiscal year 2018Operating cash flow−100.8Capital expenditure−1.4Free cash flow−102.2Fiscal year 2019Operating cash flow−96.4Capital expenditure−1.6Free cash flow−98.1Fiscal year 2020Operating cash flow−38.6Capital expenditure−0.5Free cash flow−39.1Fiscal year 2021Operating cash flow−52.1Capital expenditure−0.3Free cash flow−52.4Fiscal year 2022Operating cash flow−67.6Capital expenditure−0.6Free cash flow−68.2Fiscal year 2023Operating cash flow−78.3Capital expenditure−1.3Free cash flow−79.6Fiscal year 2024Operating cash flow−20.1Capital expenditure−0.1Free cash flow−20.2Fiscal year 2025Operating cash flow−47.1Capital expenditure−0.1Free cash flow−47.2
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −34.6 −54.7 −100.8 −96.4 −38.6 −52.1 −67.6 −78.3 −20.1 −47.1
Capital expenditure −0.2 −1.2 −1.4 −1.6 −0.5 −0.3 −0.6 −1.3 −0.1 −0.1
Free cash flow −34.8 −55.9 −102.2 −98.1 −39.1 −52.4 −68.2 −79.6 −20.2 −47.2
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash30.2Shareholders’ equity169.5Fiscal year 2017Cash20.2Shareholders’ equity225.3Fiscal year 2018Cash57.0Total debt29.9Net cash (debt)27.1Shareholders’ equity215.1Debt to equity0.14Fiscal year 2019Cash34.2Shareholders’ equity69.9Fiscal year 2020Cash22.1Total debt10.7Net cash (debt)11.4Shareholders’ equity37.7Debt to equity0.28Fiscal year 2021Cash27.3Shareholders’ equity197.3Fiscal year 2022Cash45.3Shareholders’ equity197.6Fiscal year 2023Cash39.9Shareholders’ equity157.2Fiscal year 2024Cash24.6Shareholders’ equity155.6Fiscal year 2025Cash20.0Shareholders’ equity103.1
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 30.2 20.2 57.0 34.2 22.1 27.3 45.3 39.9 24.6 20.0
Total debt n/a n/a 29.9 n/a 10.7 n/a n/a n/a n/a n/a
Net cash (debt) n/a n/a 27.1 n/a 11.4 n/a n/a n/a n/a n/a
Shareholders’ equity 169.5 225.3 215.1 69.9 37.7 197.3 197.6 157.2 155.6 103.1
Debt to equity n/a n/a 0.14 n/a 0.28 n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025† 31 Dec 2025
Revenue and profit
n/a 1.7 6.2 4.2 6.5 6.8 29.8 31.2 18.7 7.8
Growth +265.5% −31.3% +53.3% +4.3% +340.1% +5.0% −40.1% −58.2%
n/a 1.2 4.3 4.1 5.1 4.7 4.0 3.4 2.8 2.1
n/a 0.5 3.2 n/a n/a n/a n/a n/a n/a n/a
Growth +580.9%
33.5 35.8 60.8 64.2 29.3 43.8 77.8 98.4 33.6 52.6
11.8 18.9 25.8 27.8 20.5 23.6 25.1 32.4 22.2 22.0
−48.6 −54.4 −84.8 −111.1 −50.9 −89.7 −89.9 −97.4 −141.9 −76.4
Growth
−48.1 −70.4 −82.1 −113.5 −51.3 −90.9 −86.9 −88.8 −132.1 −64.9
n/a −1.8 n/a n/a −0.2 n/a n/a −0.4 n/a n/a
−48.1 −68.5 −132.7 −161.4 −51.0 −90.9 −86.9 −88.5 −132.1 −64.9
Growth
Per share
n/a n/a n/a −3.90 −1.20 −1.60 −1.33 −1.27 −1.71 −0.53
n/a n/a n/a −3.90 −1.20 −1.60 −1.33 −1.27 −1.71 −0.53
Growth
n/a n/a n/a 41.3 42.5 56.7 65.2 69.8 77.3 122.6
n/a n/a n/a 41.3 42.5 56.7 65.2 69.8 77.3 122.6
Growth +2.9% +33.4% +15.0% +7.0% +10.7% +58.6%

† The diluted share count jumps at 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 3.8% a year over five years.
  • Operating margin is down 190.5 points on five years ago, at -975.9%.
  • A net loss in 10 of 10 years on file.